0
0

Department of Veterans Affairs Awarded a Contract to NOVO NORDISK INC for $598,189,800.00

Signed on

9/22/2020, 12:00 AM

NOVO NORDISK INC Government Contract #36E79720D0071

NOVO NORDISK INC was awarded a contract with the United States Government for $598,189,800.00. The contract was awarded by the agency office NAC PHARMACEUTICALS (36E797), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

The recipient of the federal contract is Novo Nordisk Inc, a foreign-owned pharmaceutical company based in Plainsboro, New Jersey. The contract, funded by the Department of Veterans Affairs, is for the supply of Semaglutide Injection Solution (Ozempic) starting from November 2, 2020, with a total contract value of $598,189,800. There are no notable spending patterns or transactions listed in the provided data.

Contract Details

Contract ID36E79720D0071
Contract TypeIDV_B_A
Total Obligation$0.00
Exercised Options
Base Amount + Options$598,189,800.00
Date Signed2020-09-22
Contract DescriptionNEW NATIONAL CONTRACT AWARD FOR SEMAGLUTIDE INJ SOLN (OZEMPIC) WITH NOVO NORDISK. PERIOD OF PERFORMANCE IS 11/02/2020 THROUGH 11/01/2021 WITH FOUR ONE-YEAR OPTION PERIODS.
Start Date2020-11-02
End Date2025-11-01

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding OfficeNAC PHARMACEUTICALS (36E797)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding OfficeNAC PHARMACEUTICALS (36E797)

Recipient Details

RecipientNOVO NORDISK INC
Recipient Location800 SCUDDERS MILL RD PLAINSBORO NEW JERSEY, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Foreign Owned, Foreign-Owned and U.S.-Incorporated Business, Manufacturer of Goods, Not Designated a Small Business, Special Designations

Comments

Award Transactions